GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
Authors
Keywords
-
Journal
Vaccines
Volume 10, Issue 7, Pages 1034
Publisher
MDPI AG
Online
2022-06-29
DOI
10.3390/vaccines10071034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of vaccines in combatting antimicrobial resistance
- (2021) Francesca Micoli et al. NATURE REVIEWS MICROBIOLOGY
- Immunogenicity Assessment of Different Segments and Domains of Group A Streptococcal C5a Peptidase and Their Application Potential as Carrier Protein for Glycoconjugate Vaccine Development
- (2021) Guirong Wang et al. Vaccines
- Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application
- (2021) Noemi Furuyama et al. Biomed Research International
- GMMA-Based Vaccines: The Known and The Unknown
- (2021) Francesca Mancini et al. Frontiers in Immunology
- Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models
- (2021) Francesca Micoli et al. Frontiers in Immunology
- An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection
- (2021) Peter A. van der Ley et al. Frontiers in Immunology
- Gold nanoparticles morphology does not affect the multivalent presentation and antibody recognition of Group A Streptococcus synthetic oligorhamnans
- (2020) Olimpia Pitirollo et al. BIOORGANIC CHEMISTRY
- OMV Vaccines and the Role of TLR Agonists in Immune Response
- (2020) Francesca Mancini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
- (2020) Francesca Micoli et al. Vaccines
- The path to group A Streptococcus vaccines: WHO research and development technology roadmap and preferred product characteristics
- (2019) Johan Vekemans et al. CLINICAL INFECTIOUS DISEASES
- Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein
- (2019) Lingling Xu et al. VACCINE
- Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture
- (2019) Zoltán Kis et al. Biotechnology Journal
- Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development
- (2019) Fikri Avci et al. mSphere
- Group A Streptococcus Cell Wall Oligosaccharide-Streptococcal C5a Peptidase Conjugates as Effective Antibacterial Vaccines
- (2019) Subo Wang et al. ACS Infectious Diseases
- Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
- (2018) Francesca Micoli et al. MOLECULES
- Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial
- (2018) Silvana Sekuloski et al. PLoS One
- Optimizing NBE PK/PD assays using the Gyrolab Affinity Software; conveniently within the bioanalyst's existing workflow
- (2018) Maria Myzithras et al. Bioanalysis
- Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants
- (2018) Kuang Tan et al. Frontiers in Microbiology
- Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
- (2018) Francesca Micoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycoconjugate vaccines: Principles and mechanisms
- (2018) Rino Rappuoli Science Translational Medicine
- Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015
- (2017) David A. Watkins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella
- (2017) G. De Benedetto et al. VACCINE
- High-yield production of recombinant CRM197, a non-toxic mutant of diphtheria toxin, in the periplasm of Escherichia coli
- (2017) Philippe Goffin et al. Biotechnology Journal
- The effect of preexisting anti-carrier immunity on subsequent responses to CRM197or Qb-VLP conjugate vaccines
- (2016) Michael J. McCluskie et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Status of research and development of vaccines for Streptococcus pyogenes
- (2016) Andrew C. Steer et al. VACCINE
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- The Classical Lancefield Antigen of Group A Streptococcus Is a Virulence Determinant with Implications for Vaccine Design
- (2014) Nina M. van Sorge et al. Cell Host & Microbe
- Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)
- (2014) Liesl Zühlke et al. EUROPEAN HEART JOURNAL
- A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development
- (2014) Martina Sanderson-Smith et al. JOURNAL OF INFECTIOUS DISEASES
- Overprescribing and Inappropriate Antibiotic Selection for Children With Pharyngitis in the United States, 1997-2010
- (2014) Kathleen L. Dooling et al. JAMA Pediatrics
- Structural analysis of O-polysaccharide chains extracted from different Salmonella Typhimurium strains
- (2013) Francesca Micoli et al. CARBOHYDRATE RESEARCH
- Hepatitis B core–based virus–like particles to present heterologous epitopes
- (2013) Kenny Roose et al. Expert Review of Vaccines
- StreptInCor: A Candidate Vaccine Epitope against S. pyogenes Infections Induces Protection in Outbred Mice
- (2013) Edilberto Postol et al. PLoS One
- Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants
- (2013) Harm HogenEsch Frontiers in Immunology
- Rheumatic heart disease
- (2012) Eloi Marijon et al. LANCET
- Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case
- (2012) Giuliano Bensi et al. MOLECULAR & CELLULAR PROTEOMICS
- New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci
- (2011) James B. Dale et al. VACCINE
- Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate
- (2010) Anna Kabanova et al. VACCINE
- Glycoconjugate vaccines and immune interference: A review
- (2010) Ron Dagan et al. VACCINE
- Global emm type distribution of group A streptococci: systematic review and implications for vaccine development
- (2009) Andrew C Steer et al. LANCET INFECTIOUS DISEASES
- Rheumatic Heart Disease in Asia
- (2008) Jonathan R. Carapetis CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started